Denver Alzheimer’s Researcher Plays Key Role in Colorado COVID-19 Response
Written By: BrightFocus Editorial Staff
Written By: BrightFocus Editorial Staff
University of Denver Alzheimer’s researcher Lotta Granholm-Bentley, PhD, DDS, is playing a key role in her community’s medical response to the coronavirus, and working with Colorado seniors to help combat the sense of isolation many are feeling during these difficult times.
In addition to serving on an advisory board to help Colorado Governor Jared Polis with the impact of the virus on the state’s older residents, Dr. Granholm-Bentley led a campus-wide collection of donated medical supplies including gloves and masks.
“We made gallons of hand sanitizer (according to a World Health Organization recipe: aloe, ethanol and tea tree oil) and delivered these and the medical supplies to area home care and assisted living facilities,” said Dr. Granholm-Bentley.
Granholm-Bentley created a series of “how-to” communications tips and tools about how to connect during this time of COVID-19 isolation. She noted, “Many people, particularly the elderly and those in rural areas of the state, and the country, would benefit from knowing how to do calls via Zoom or Skype.”
These tips are posted on her center’s website and have been shared with thousands of older adults around Colorado.
Even in the face of the pandemic’s many challenges, Dr. Granholm-Bentley remains optimistic, “Everyone here in Colorado is very helpful and these activities make us not go crazy in a time of isolation!”
Dr. Granholm-Bentley is the founding Executive Director of the Knoebel Institute for Healthy Aging and is a research professor in the Department of Biological Sciences at the University of Denver. She is leading a BrightFocus-funded effort to better understand Down syndrome-related Alzheimer’s disease. According to Granholm-Bentley, as many as 80 percent of the Down syndrome population will develop Alzheimer’s pathology in their 50s and 60s.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
University of Colorado